Stemgen, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021
StemGen, Inc. announced earnings results for the third quarter ended March 31, 2021. For the third quarter, the company announced operating loss was USD 57,308 compared to USD 11,786 a year ago. Net loss was USD 98,237 compared to USD 52,703 a year ago. For the nine months, sales was USD 39,000 compared to USD 1,750 a year ago. Operating loss was USD 151,462 compared to USD 45,810 a year ago. Net loss was USD 299,751 compared to USD 168,582 a year ago.